Literature DB >> 10635285

The effects of antimicrobial mouthrinses on oral malodor and their status relative to US Food and Drug Administration regulations.

W J Loesche1.   

Abstract

This study was undertaken to review the rationale behind the usage of antibacterial mouthrinses to control oral malodor and to evaluate the claims made for antibacterial mouthrinses against the statements of US Food and Drug Administration regulations. The literature from 1960 to August 1997, found in a MEDLINE search on oral malodor, halitosis, and tongue microbiology, was examined. Clinical trials that were double blind and had selected subjects who exhibited a detectable level of oral malodor were evaluated. Individuals who experience oral malodor resulting from the overgrowth of proteolytic, anaerobic bacteria on their tongue surfaces can be successfully treated by a regimen that includes tongue brushing and toothbrushing, often in combination with use of a mouthrinse containing an antibacterial agent. Several candidate mouthrinses containing essential oils, zinc chloride, or an oil-water-cetylpyridinium chloride mouthrinse have reduced the organoleptic scores of individuals with moderate levels of oral malodor in the absence of tongue brushing. Very little long-term data beyond 6 weeks of usage are available. These mouthrinses should be marketed as oral deodorants that are analogous in purpose to the usage of deodorant soaps to control and/or eliminate body malodors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10635285

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  2 in total

1.  Correlation of oral hygiene practices, smoking and oral health conditions with self perceived halitosis amongst undergraduate dental students.

Authors:  Saniya Setia; Parampreet Pannu; Ramandeep Singh Gambhir; Virat Galhotra; Pooja Ahluwalia; Anjali Sofat
Journal:  J Nat Sci Biol Med       Date:  2014-01

2.  Does propolis help to maintain oral health?

Authors:  Włodzimierz Więckiewicz; Marta Miernik; Mieszko Więckiewicz; Tadeusz Morawiec
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-09       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.